Stock News - Kezar Life Sciences, Inc. $KZR
Latest Stock News for $KZR
Kezar Life Sciences Terminates Lease and Announces Executive Departures Amid Merger Plans
Expected Stock impact: Slightly Negative
2026-04-03 20:50:33
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 per Share Plus Contingent Value Right
Expected Stock impact: Very Positive
2026-03-30 12:34:24
Kezar Life Sciences Sells Sec61 Program Assets to Enodia Therapeutics for Up to $127 Million
Expected Stock impact: Noticeably Positive
2026-03-12 16:43:32
